For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Key Findings
The global market of metagenomics is forecasted to grow at a CAGR of 15.21% between the years 2019-2027. Along with the study of the interaction of microbes, metagenomics also consists the analysis of the collective genomes.
Market Insights
The factors responsible for the growth of metagenomics market is the increase in metagenomics experiments collaboration, adoption of metagenomics application and growing advanced sequencing platforms. A collaboration between the scientific experiments and computing technologies is driving the metagenomics market through the experiments collaboration. The consumables product segment generated the highest revenue in 2018 and is expected to stay dominant throughout the forecast period.
Based on application, the infectious disease diagnosis segment has registered the fastest growth rate throughout the forecast period. Two commonly used metagenomics methods in the pathogen identification of infectious disease diagnosis include deep amplicon sequencing and whole-genome shotgun metagenomics. However, the metagenomics market faces some troubles when it comes to the availability of skilled personnel and regulations.
Regional Insights
Based on geography, the global metagenomics market has been segmented into geographical regions, which include North America, Europe, Asia-Pacific, and Rest of the World. The major countries considered in every region are, North America (the United States, and Canada), Europe (United Kingdom, France, Germany, Italy, Spain and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of Asia Pacific). Rest of World segment includes key regions such as Latin America & Middle East and Africa.
In 2018, the majority of market share was captured by North America in the Global metagenomics market by region. North America contributed approx. xx% of market share in 2018 & is estimated to contribute the majority of share to remain at approx. xx% by 2027 as compared to 2018. On the other hand, Asia-Pacific is anticipated to be the fastest growing region in the market with a CAGR of xx% during the forecast period 2019-2027.
Competitive Insights
Some of the leading players in the market are Agilent Technologies Inc., Interagen SA, Oxford nanopore technology, Perkin Elmer Inc., Bio-Rad Laboratories Inc., Enterome SA, F Hoffman La-Roche Ltd, Qiagen NV, Swift Biosciences Inc., Pacific Biosciences of California, Illumina Inc., Takara Bio Inc. and Thermo Fisher Scientific Inc.